[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting

KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …

Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives

N Lepareur, F Lacœuille, C Bouvry, F Hindré… - Frontiers in …, 2019 - frontiersin.org
Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h
physical half-life, which has been shown to be a very attractive candidate for use in …

Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair

Y Zeng, J Hoque, S Varghese - Acta biomaterialia, 2019 - Elsevier
Although bone tissues possess an intrinsic capacity for repair, there are cases where bone
healing is either impaired or insufficient, such as fracture non-union, osteoporosis …

Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics

SG Rotman, DW Grijpma, RG Richards… - Journal of controlled …, 2018 - Elsevier
The systemic administration of drugs to treat bone diseases is often associated with poor
uptake of the drug in the targeted tissue, potential systemic toxicity and suboptimal efficacy …

Clinical advances and perspectives in targeted radionuclide therapy

N Lepareur, B Ramée, M Mougin-Degraef… - Pharmaceutics, 2023 - mdpi.com
Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …

Recent advances in bone-targeted therapy

C Shi, T Wu, Y He, Y Zhang, D Fu - Pharmacology & therapeutics, 2020 - Elsevier
The coordination between bone resorption and bone formation plays an essential role in
keeping the mass and microstructure integrity of the bone in a steady state. However, this …

Phosphorylation of arenes, heteroarenes, alkenes, carbonyls and imines by dehydrogenative cross-coupling of P (O)–H and P (R)–H

S Hore, RP Singh - Organic & Biomolecular Chemistry, 2022 - pubs.rsc.org
Organophosphorous compounds have recently emerged as a powerful class of compounds
with widespread applications, such as in bioactive natural products, pharmaceuticals …

Advances in macrocyclic chelators for positron emission tomography imaging

M Li, S Wang, Q Kong, X Cheng, H Yan, Y Xing, X Lan… - View, 2023 - Wiley Online Library
In recent years, radiometals have been successfully applied to medicine because of their
breadth of decay properties and increased production and availability. Bifunctional chelators …

Novel radiolabeled bisphosphonates for PET diagnosis and endoradiotherapy of bone metastases

N Pfannkuchen, M Meckel, R Bergmann, M Bachmann… - Pharmaceuticals, 2017 - mdpi.com
Bone metastases, often a consequence of breast, prostate, and lung carcinomas, are
characterized by an increased bone turnover, which can be visualized by positron emission …

From bench to bedside—the bad Berka experience with first-in-human studies

J Zhang, A Singh, HR Kulkarni, C Schuchardt… - Seminars in nuclear …, 2019 - Elsevier
Precision oncology is being driven by rapid advances in novel diagnostics and therapeutic
interventions, with treatments targeted to the needs of individual patients on the basis of …